Computer programs may reduce the rate of drug trial failures

Researchers have started using powerful computer simulations to design clinical trials, potentially reducing the failure rate and getting drugs to market faster. The simulators show whether a drug will yield statistically significant results using a certain set of test parameters. A recently approved simulator for Alzheimer's disease treatments incorporates data from previous trials, published papers and an NIH neuroimaging study.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ